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The African Journal of Emergency Medicine (AfJEM, ISSN: 2211-419X) is the official journal of the
African Federation for Emergency Medicine. It is an international, peer-reviewed journal aimed in
particular at supporting emergency care across Africa. AfJEM publishes original research, reviews,
brief reports of scientific investigations, case reports as well as commentary and correspondence
related to topics of scientific, ethical, social and economic importance to emergency care in Africa.
Articles will be of direct importance to African emergency care, but may have originated from
elsewhere in the world.
TYPES OF ARTICLES
Original Article: Original studies of basic or clinical investigations in areas relevant to emergency
medicine. Reference to the relevance of the research in a resource poor setting is essential and
should be alluded to in the discussion section. References and a structured abstract (see Preparation
below) are required. Maximum length: 3,000 words, 5 tables and/or figures, plus the abstract (300
words) and references (max 50). The checklists found on the following websites should be used to
structure your manuscript (a copy of the checklist indicating which elements of the reporting format
you adhered to, a signed conflict of interest form and Additional material form- see below- should
be submitted with your manuscript):
a. For randomised control trials: http://www.consort-statement.org
b. For cohort, case-control, and cross-sectional studies: http://www.strobe-statement.org/
c. All other studies: http://www.equator-network.org/
2. Review Articles: Extensive reviews of the literature on a narrow clinical topic. References must
include, but need not be limited to, the past 3 years of the literature. A structured abstract is required
(see Preparation below). Maximum length: 3,000 words, plus the narrative abstract (max 300 words)
and references (max 50). Please contact the editor in chief before you submit a review. The
following reporting checklists should be used to structure your manuscript (a copy of the checklist
indicating which elements of the reporting format you adhered to, a signed conflict of interest form
and Additional material form- see below- should be submitted with your manuscript):
a. A Resourced-tiered review checklist is the standard reporting format for publication in AfJEM:
http://www.afjem.com/resource-tiered-checklist.html
b. If your topic does not lean itself towards a resourced tiered review consider alternative
reporting checklists for systematic reviews and meta-analyses such as Prisma checklist
(http://www.prisma-statement.org ) or similar. Please check with the editor-in-chief before
using a checklist other that the resources-tiered checklist.
3. Case Reports: Brief descriptions of a previously undocumented disease process, a unique
unreported manifestation or treatment of a known disease process, or unique unreported
complications of treatment regimens. Case reports should be structured as follow: Introduction, Case
report and Discussion. It should not contain an exhaustive review of the literature. Consider consent
for patient identifiable information (download from website). A structured abstract (see Preparation
below) is required. Maximum length: 1,000 words, plus abstract (max 150 words) and references
(max 10), and 1 table or figure a copy of the checklist indicating which elements of the reporting
format you adhered to, a signed conflict of interest form and Additional material form- see below-
should be submitted with your manuscript). Case reports listed for publication after 2015 are published
online only and compiled within a virtual issue once a year.
4. Practical Pearl(upload as Technical note): Descriptions of novel approaches to provision of
emergency care; and practical "tricks of the trade" describing aspects of emergency medicine
management. An abstract is not required (enter: Not required, practical pearl when prompted).
Maximum length: 800 words, 5 tables and/or figures and references (max 5). A manuscript template
is available at http://www.afjem.com/#author  and can be used for submission (a signed conflict of
interest form- see below- should be submitted with your manuscript). Note that author details should
be included in the manuscript.
5. Abbreviated paper (previously Brief Research Reports): Reports of preliminary data and findings
or studies with small numbers demonstrating the need for further investigation. References and a
structured abstract (see Preparation below) are required. Maximum length: 1,500 words, plus the
abstract (max 300 words) and references (max 10) and 3 tables and/or figures. Checklists described
AUTHOR INFORMATION PACK 4 Nov 2016 www.elsevier.com/locate/afjem
for original research above should be used to structure your manuscript (a copy of the checklist
indicating which elements of the reporting format you adhered to, a signed conflict of interest form
and Additional material form- see below- should be submitted with your manuscript)
6. Commentary: Descriptions of clinical and nonclinical problems and solutions; descriptions of novel
approaches to planning, management, or provision of emergency services; and practical " how-to"
articles describing aspects of emergency medicine management (includes African country acute care
profiles) . A narrative abstract (see Preparation below) is required. Maximum length: 3,000 words,
plus the abstract (max 300 words) and references (max 50). A signed conflict of interest form- see
below- should be submitted with your manuscript.
7. Editorials (commissioned and including op-ed): Authoritative comments or opinions on major
current problems of emergency physicians or on controversial matters with significant implications
for emergency medicine; or, qualified, thorough analysis and criticism of articles appearing in AfJEM.
Maximum length: 1,500 words plus references (max 5). An abstract is not required. A signed conflict
of interest form- see below- should be submitted with your manuscript.
8. Correspondence: Discussion, observations, opinions, corrections, and comments on topics
appearing in AfJEM; very brief reports or other items of interest. Maximum length: 500 words, plus
references (max 5). An abstract is not required. Please enter: Not applicable, Correspondence when
prompted to enter an abstract. Letters discussing an AfJEM article should be received within 6 weeks
of the article's publication. The article must be included in the references. Authors of articles about
which letters are received will be given the opportunity to reply, which will not be shared with the letter
writer prior to publication. Letters of political or other topics unrelated to the science of medicine, as
well as those containing personal criticisms, will not be published. A signed conflict of interest form-
see below- should be submitted with your manuscript
9. Erratum: Corrections on topics appearing in AfJEM. Maximum length: 300 words, plus references
(max 5). An abstract is not required. Please enter: Not applicable, Erratum when prompted to enter
an abstract. Letters discussing an AfJEM article should be received within 6 weeks of the article's
publication. The article must be included in the references. Authors of articles about which letters
are received will be given the opportunity to reply, which will not be shared with the letter writer
prior to publication. Letters of political or other topics unrelated to the science of medicine, as well
as those containing personal criticisms, will not be published elsewhere including electronically in the
same form, in English or in any other language, without the written consent of the copyright-holder.
A signed conflict of interest form- see below- should be submitted with your manuscript.
Submission
Our online submission system guides you stepwise through the process of entering your article
details and uploading your files. The system converts your article files to a single PDF file used in
the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for
final publication. All correspondence, including notification of the Editor's decision and requests for
revision, is sent by e-mail.
Please submit your article via http://ees.elsevier.com/afjem/
Submission checklist
You can use this list to carry out a final check of your submission before you send it to the journal for
review. Please check the relevant section in this Guide for Authors for more details.
Ensure that the following items are present:
One author has been designated as the corresponding author with contact details:
• E-mail address
• Full postal address
All necessary files have been uploaded:
Manuscript:
• Include keywords
• All figures (include relevant captions)
• All tables (including titles, description, footnotes)
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• Ensure all figure and table citations in the text match the files provided
• Indicate clearly if color should be used for any figures in print
Graphical Abstracts / Highlights files (where applicable)
Supplemental files (where applicable)
Further considerations
• Manuscript has been 'spell checked' and 'grammar checked'
• All references mentioned in the Reference List are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the
Internet)
• Relevant declarations of interest have been made
• Journal policies detailed in this guide have been reviewed
• Referee suggestions and contact details provided, based on journal requirements
For further information, visit our Support Center.
BEFORE YOU BEGIN
Ethics in Publishing
For information on Ethics in Publishing and Ethical guidelines for journal publication see
http://www.elsevier.com/publishingethics and http://www.elsevier.com/ethicalguidelines. The work
described in your article must have been carried out in accordance with The Code of
Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving
humans http://www.wma.net/en/30publications/10policies/b3/index.html; EC Directive 86/609/EEC
for animal experiments http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm;
Uniform Requirements for manuscripts submitted to Biomedical journals http://www.icmje.org. AfJEM
is a member of the Committee on Publication Ethics (COPE) which advises on the management of
cases where research or publication misconduct occurred (http://publicationethics.org/). Consent
forms for patients (if required) can be downloaded in both English and French.
Plagiarism detection AfJEM is a member of iThenticate. iThenticate is a plagiarism screening service
that verifies the originality of content submitted before publication. iThenticate checks submissions
against millions of published research papers, and millions of pages of web content. Authors,
researchers and freelancers can also use iThenticate to screen their work before submission by visiting
http://www.ithenticate.com/
Conflict of interest
Collate conflicts of interest in a separate section at the end of the article before the acknowledgements
and do not, therefore, include them on the title page, as a footnote to the title or otherwise. If no
conflict of interest exists please state: The author(s) declare no conflict of interest Conflicts of interests
that require disclosure include, but are not limited to:
a. Associations with commercial entities that provided support for the work reported in the submitted
manuscript (the timeframe for disclosure in this section of the form is the life span of the work being
reported).
b. Associations with commercial entities that could be viewed as having an interest in the general
area of the submitted manuscript (in the three years before submission of the manuscript).
c. Non-financial associations that may be relevant or seen as relevant to the submitted manuscript.
Example: I the author (/We, the authors), declare the following interests: AA has received speaker
fees from BBB company. CC has received fees as an advisory board member for DDD company. EE's
institution receives funding from FFF company for a trial in which he is co-investigator
Submission declaration
Submission of an article implies that the work described has not been published previously (except in
the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint,
see 'Multiple, redundant or concurrent publication' section of our ethics policy for more information),
that it is not under consideration for publication elsewhere, that its publication is approved by all
authors and tacitly or explicitly by the responsible authorities where the work was carried out, and
that, if accepted, it will not be published elsewhere including electronically in the same form, in English
or in any other language, without the written consent of the copyright-holder.
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Authorship
All authors should have made substantial contributions to all of the following: (1) the conception and
design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the
article or revising it critically for important intellectual content, (3) final approval of the version to
be submitted.
Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their
manuscript and provide the definitive list of authors at the time of the original submission. Any
addition, deletion or rearrangement of author names in the authorship list should be made only
before the manuscript has been accepted and only if approved by the journal Editor. To request such
a change, the Editor must receive the following from the corresponding author: (a) the reason
for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they
agree with the addition, removal or rearrangement. In the case of addition or removal of authors,
this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of
authors after the manuscript has been accepted. While the Editor considers the request, publication
of the manuscript will be suspended. If the manuscript has already been published in an online issue,
any requests approved by the Editor will result in a corrigendum.
Clinical trial results
In line with the position of the International Committee of Medical Journal Editors, the journal will not
consider results posted in the same clinical trials registry in which primary registration resides to be
prior publication if the results posted are presented in the form of a brief structured (less than 500
words) abstract or table. However, divulging results in other circumstances (e.g., investors' meetings)
is discouraged and may jeopardise consideration of the manuscript. Authors should fully disclose all
posting in registries of results of the same or closely related work.
Article transfer service
This journal is part of our Article Transfer Service. This means that if the Editor feels your article is
more suitable in one of our other participating journals, then you may be asked to consider transferring
the article to one of those. If you agree, your article will be transferred automatically on your behalf
with no need to reformat. Please note that your article will be reviewed again by the new journal.
More information.
Journal rights
For articles published in AfJEM Elsevier uses an Exclusive License Agreement to define these rights.
For articles published in AfJEM Elsevier uses an Exclusive License Agreement to define these rights.
Under this license the rights granted to AfJEM include: An exclusive right to publish and distribute
an article. The right to provide the article in all forms and media so the article can be used on
the latest technology even after publication. The right to publish and disseminate the article under
Creative Commons Attribution Non-Commercial No Derivatives (CC-BY-NC-ND) for the purposes of
Open Access publication. Additional rights to enforce the rights in the work, on behalf of an author,
against third parties in the case of plagiarism, ethic disputes and fraud.Author rights: As an author
you (or your employer or institution) retain certain rights: Patent, trademark and other intellectual
property rights in the article The right for proper attribution and credit for the published work The
right to reuse their own work in the same way readers can as defined by CC-BY-NC-ND license.
For further details you are referred to:
http://www.elsevier.com/about/company-information/policies/copyright. User rights: The CC-BY-NC-
ND licence is used to govern the terms on which an article can be reused. CC-BY-NC-ND allows users
to copy and distribute the article, provided this is not done for commercial purposes and the article
is not changed or edited in any way. The author must be attributed and must not be represented as
endorsing the use made of the work.
Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.
Open access (OA)
There is no publication fee for this journal. On publication, articles are made freely available to all
(including non-subscribers) via the ScienceDirect platform. Learn more about Elsevier's pricing policy:
http://www.elsevier.com/openaccesspricing
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Elsevier Publishing Campus
The Elsevier Publishing Campus (www.publishingcampus.com) is an online platform offering free
lectures, interactive training and professional advice to support you in publishing your research. The
College of Skills training offers modules on how to prepare, write and structure your article and
explains how editors will look at your paper when it is submitted for publication. Use these resources,
and more, to ensure that your submission will be the best that you can make it.
Language and language services
Please write your text in UK English by setting your word processor to English (U.K.).
Authors who require information about language editing and copyediting services pre- and post-
submission please visit http://webshop.elsevier.com/languageediting or our customer support site at
http://support.elsevier.com for more information. Also see Author Assist below.
Author Assist It is the aim of the AfJEM to be representative of all parts of the African continent; we
recognise within this that some African researchers in emergency care may be disadvantaged in the
available range of journals into which they can publish their work. We are aware that this is due to
many reasons, including that topics are concerned with www.afjem.com conditions which are largely
irrelevant to other audiences. AfJEM is dedicated to supporting all authors who wish to publish on an
African emergency care topic. In order to maintain and produce a high quality, international standard
Emergency Medicine journal, AfJEM has devised Author Assist. AfJEM enlists the help of a team of
experienced volunteers (Author Assistants) to help improve the quality of manuscripts before peer-
review submission. Go to http://www.afjem.com/author-assistance.html for more information.
Submission
Our online submission system guides you stepwise through the process of entering your article
details and uploading your files. The system converts your article files to a single PDF file used in
the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for
final publication. All correspondence, including notification of the Editor's decision and requests for
revision, is sent by e-mail.
Submit your article
Please submit your article via http://ees.elsevier.com/afjem.
Peer review and Referees
Each paper submitted to the journal is firstly checked for completeness and similarity by the technical
editor followed by an initial desk review by one of the editors-in-chief. Papers not suitable for
publication are either rejected outright (out-of-scope) or rejected- refer Author Assist (within scope,
but poor quality). This is usually done within the first three to five days. Papers accepted for peer
review are then assigned to an associate editor who takes responsibility for assigning peer reviewers
and providing a synthesis of reviews to the editor-in-chief for a decision. All original content submitted
to the AfJEM is peer reviewed by a minimum of two and up to four reviewers. Editorials, op-ed pieces
and regular features are reviewed by a single expert reviewer, usually an associate editor of the
journal. Peer review is double blinded (authors and reviewers never learn each others identities). The
latter is specifically required to compliment the Author Assist process. AfJEM operates a strict peer
reviewer code of conduct policy. Details can be found in the Reviewer Area on http://www.afjem.com.
Authors are encouraged to submit the names and institutional e-mail addresses of several potential
referees. For more details, visit our Support site. Note that an editor retains the sole right to decide
whether or not the suggested reviewers are used.
PREPARATION
Use of word processing software
It is important that the file be saved in the native format of the word processor used. The text
should be in single-column format. Keep the layout of the text as simple as possible. Most formatting
codes will be removed and replaced on processing the article. In particular, do not use the word
processor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts,
superscripts etc. When preparing tables, if you are using a table grid, use only one grid for each
individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns.
The electronic text should be prepared in a way very similar to that of conventional manuscripts (see
also the Guide to Publishing with Elsevier). Note that source files of figures, tables and text graphics
will be required whether or not you embed your figures in the text. See also the section on Electronic
artwork.
AUTHOR INFORMATION PACK 4 Nov 2016 www.elsevier.com/locate/afjem
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check'
functions of your word processor.
Article Structure
Ensure that author identifiers are not included in the main manuscript file submitted. Inclusion of an
abstract in the manuscript is not required. Consult the guidance and checklists described in Types of
Articles above to structure your manuscript correctly. All article types will require the signed conflict
of interest form to be submitted as a supplementary file. Original articles, abbreviated papers, case
reports and review articles will require the reporting checklist and Additional material form to be
submitted as supporting files. Where these have not been supplied, the manuscript will be returned
to the author.
Subdivision
Divide your article into clearly defined sections as per the guidance given in Types of Articles above.
Numbers are not to be used for sections or subsections. Section headings should be in bold.
Subsection headings should be in italics. Each heading should appear on its own separate line.
Subsections in addition to the sections described in Types of Articles above should be used sparingly.
Clinical trial results
In line with the position of the International Committee of Medical Journal Editors, the journal will not
consider results posted in the same clinical trials registry in which primary registration resides to be
prior publication if the results posted are presented in the form of a brief structured (less than 500
words) abstract or table. However, divulging results in other circumstances (e.g., investors' meetings)
is discouraged and may jeopardise consideration of the manuscript. Authors should fully disclose all
posting in registries of results of the same or closely related work.
Discussion
This should explore the significance of the results of the work, not repeat them. A combined Results
and Discussion section is often appropriate. Avoid extensive citations and discussion of published
literature.
Conclusions
The main conclusions of the study may be presented in a short Conclusions section, which may stand
alone or form a subsection of a Discussion or Results and Discussion section.
Appendices
If there is more than one appendix, it should be identified starting with Appendix B, C, etc. Do not use
Appendix A. Formulae and equations in appendices should be given separate numbering: Eq. (B.1),
Eq. (B.2), etc.; in a subsequent appendix, Eq. (C.1) and so on. Similarly for tables and figures: Table
B.1; Fig. B.1, etc. All appendices will be considered online material only.
Essential Title Page Information
• Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid
abbreviations and formulae where possible.
• Author names and affiliations. Where the family name may be ambiguous (e.g., a double name),
please indicate this clearly. Present the authors' affiliation addresses (where the actual work was
done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after
the author's name and in front of the appropriate address. Provide the full postal address of each
affiliation, including the country name and, if available, the e-mail address of each author.
• Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing
and publication, also post-publication. Ensure that phone numbers (with country and area
code) are provided in addition to the e-mail address and the complete postal address.
Contact details must be kept up to date by the corresponding author.
• Present/permanent address. If an author has moved since the work described in the article was
done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as
a footnote to that author's name. The address at which the author actually did the work must be
retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
• Word count. Please provide a word count
• Table/figure count. Please provide a table/ figure count
Abstract
A concise and factual abstract of no more than 300 words is required. The abstract should state
briefly the purpose of the research, the principal results and major conclusions. An abstract is often
presented separately from the article, so it must be able to stand alone. Non-standard or uncommon
AUTHOR INFORMATION PACK 4 Nov 2016 www.elsevier.com/locate/afjem
abbreviations should be avoided, but if essential, it must be defined at the first mention. With the
exception of a submission for Editorials, Practical pearl, Correspondence and Erratum, structured
abstracts are required for all article types
Types of abstracts include:Research abstracts should adhere to the following format: Introduction,
Methods, Results and Conclusion.Case reports should adhere to the following format: Introduction,
Case report and Discussion.Narrative abstracts are acceptable for non-research abstracts (concepts
and commentary)
Keywords
The submission system will prompt authors to provide a maximum of 6 keywords, using American
spelling and avoiding general and plural terms and multiple concepts (avoid, for example, "and",
"of"). Be sparing with abbreviations: only abbreviations firmly established in the field may be eligible.
These keywords will be used for indexing purposes.
Abbreviations
Define abbreviations that are not standard in this field in a footnote to be placed on the first page
of the article. Such abbreviations that are unavoidable in the abstract must be defined at their first
mention there, as well as in the footnote. Ensure consistency of abbreviations throughout the article.
Acknowledgements
Collate acknowledgements in a separate section at the end of the article before the references and do
not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those
individuals who provided help during the research (e.g., providing language help, writing assistance
or proof reading the article, etc.).
Statistics
Describe statistical methods with enough detail to enable a knowledgeable reader with access to
the original data to verify the reported results. References for the design of the study and complex
or unusual statistical methods should be to standard works when possible (with pages stated).
Commonly used methods such as the chi-square test, t-test, ANOVA, linear and logistic regression
need not be referenced. Define statistical terms, www.afjem.com abbreviations, and most symbols.
Technical statistical terms should ideally be replaced by simpler terms where possible and referenced
if not. Specify the computer software used. The results section must be written so the average reader
can understand the findings. The methods section is allowed to be more complex if unavoidable. When
possible, quantify findings and present them with appropriate indicators of measurement error or
uncertainty (such as confidence intervals). For normally distributed data give means and confidence
intervals and for data that is not normally distributed give the median and interquartile range. Avoid
relying solely on statistical hypothesis testing, such as p-values. If p-values are used, include 2 digits
of precision (i.e. p=0.65) for values greater than 0.01. Give 3 digits for values between 0.01 and
0.001 and report values smaller than 0.001 as p < 0.001. Describing non-significant p-values as NS
is not acceptable and a numerical value should be given. When using tables consider including counts
and percentages. In general, including the chi-square statistic, t statistic, F statistic and degrees of
freedom is not useful. Regression output should be limited to the most important findings. Estimates
of variance explained (R2, correlation coefficients, and standardised regression coefficients or effect
size) should not be presented as the main result of the analysis.
Math Formulae
Present simple formulae in the line of normal text where possible and use the solidus (/) instead of a
horizontal line for small fractional terms, e.g., X/Y. In principle, variables are to be presented in italics.
Powers of e are often more conveniently denoted by exp. Number consecutively any equations that
have to be displayed separately from the text (if referred to explicitly in the text). Bear in mind that
complex formulae, such as log likelihood expressions or symbolic expressions for regression models
are often beyond the grasp of the average reader. Consider making this available as an online only
appendix.
Footnotes
Footnotes are discouraged and when used should be used sparingly. Number them consecutively
throughout the article, using superscript Arabic numbers. Many word processors build footnotes into
the text, and this feature may be used. Should this not be the case, indicate the position of footnotes
in the text and present the footnotes themselves separately at the end of the article. Do not include
footnotes in the Reference list.
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Mandatory inclusions
Mandatory inclusions will be included in the final manuscript and will be added by the technical editor
after acceptance. It will be placed just before the acknowledgments. The documents listed below
should be included for the relevant article types as supporting files. Failure to include these will result
in the submission being returned to include.
1. Signed conflict of interest document:
Required for all article types. Download document here
2. Additional material document
Required for Original articles, Review Articles, Abbreviated papers and Case Reports. When completing
the document for a Review article only the African relevance and Author contribution sections need
to be completed. Download document here
3. Reporting checklist
Required for Original articles, Review Articles, Abbreviated papers and Case Reports. Please provide
a copy of the reporting checklist clearly indicating which elements of the reporting format has been
adhered to and which not. Provide a brief explanation for deviations from a reporting checklist
a. For randomised control trials: http://www.consort-statement.org
b. For cohort, case-control, and cross-sectional studies: http://www.strobe-statement.org/
c. For case reports: http://www.care-statement.org/
d. For Resourced-tiered review articles: http://www.afjem.com/resource-tiered-checklist.html
e. For systematic reviews and meta-analyses: http://www.prisma-statement.org
f. All other studies: http://www.equator-network.org/
Artwork
Image manipulation
Whilst it is accepted that authors sometimes need to manipulate images for clarity, manipulation for
purposes of deception or fraud will be seen as scientific ethical abuse and will be dealt with accordingly.
For graphical images, this journal is applying the following policy: no specific feature within an image
may be enhanced, obscured, moved, removed, or introduced. Adjustments of brightness, contrast,
or color balance are acceptable if and as long as they do not obscure or eliminate any information
present in the original. Nonlinear adjustments (e.g. changes to gamma settings) must be disclosed
in the figure legend.
Electronic artwork
General points
• Make sure you use uniform lettering and sizing of your original artwork.
• Embed the used fonts if the application provides that option.
• Aim to use the following fonts in your illustrations: Arial, Courier, Times New Roman, Symbol, or
use fonts that look similar.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
• Size the illustrations close to the desired dimensions of the published version.
• Submit each illustration as a separate file.
A detailed guide on electronic artwork is available.
You are urged to visit this site; some excerpts from the detailed information are given here.
Formats
If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then
please supply 'as is' in the native document format.
Regardless of the application used other than Microsoft Office, when your electronic artwork is
finalized, please 'Save as' or convert the images to one of the following formats (note the resolution
requirements for line drawings, halftones, and line/halftone combinations given below):
EPS (or PDF): Vector drawings, embed all used fonts.
TIFF (or JPEG): Color or grayscale photographs (halftones), keep to a minimum of 300 dpi.
TIFF (or JPEG): Bitmapped (pure black & white pixels) line drawings, keep to a minimum of 1000 dpi.
TIFF (or JPEG): Combinations bitmapped line/half-tone (color or grayscale), keep to a minimum of
500 dpi.
Please do not:
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• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); these typically have a
low number of pixels and limited set of colors;
• Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.
Colour artwork/ figure
Please make sure that artwork/ figure files are in an acceptable format (TIFF, EPS or MS Office
files) and with the correct resolution. If, together with your accepted article, you submit usable
colour figures then Elsevier will ensure, at no additional charge, that these figures will appear
in colour on the Web (e.g., ScienceDirect and other sites) in addition to colour reproduction
in print. For further information on the preparation of electronic artwork/ figure, please see
http://www.elsevier.com/artworkinstructions.
Artwork Figure captions
Ensure that each illustration/ figure has a caption. Supply captions separately, listed at the end of
your manuscript after the references, and not included in the separately uploaded artworks/ figures. A
caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep
text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.
Illustration services
Elsevier's WebShop offers Illustration Services to authors preparing to submit a manuscript but
concerned about the quality of the images accompanying their article. Elsevier's expert illustrators
can produce scientific, technical and medical-style images, as well as a full range of charts, tables
and graphs. Image 'polishing' is also available, where our illustrators take your image(s) and improve
them to a professional standard. Please visit the website to find out more.
Figure captions
Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A
caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep
text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.
Text graphics
Text graphics may be embedded in the text at the appropriate position. See further under Electronic
artwork.
Tables
Number tables consecutively in accordance with their appearance in the text. Place footnotes to tables
below the table body and indicate them with superscript lowercase letters. Avoid vertical rules. Be
sparing in the use of tables and ensure that the data presented in tables do not duplicate results
described elsewhere in the article.Tables should be placed within the text where it is referenced. The
preferred format for tables is as follow. Include tables in the main text of the manuscript. Each table
should be labelled at the top with footnotes at the bottom.
table 1 Title of table
Align heading leftAlign heading middle Align heading middle Align content left Align content
middle Align content middle Align content lefta Align content middleb Align content middle Align
content left Align content middle Align content middle a Footnote 1, b Footnote 2
References
Citation in text
Please ensure that every reference cited in the text is also present in the reference list (and vice
versa). Any references cited in the abstract must be given in full. Unpublished results and personal
communications are not recommended in the reference list, but may be mentioned in the text. If these
references are included in the reference list they should follow the standard reference style of the
journal and should include a substitution of the publication date with either 'Unpublished results' or
'Personal communication'. Citation of a reference as 'in press' implies that the item has been accepted
for publication.
Web references
As a minimum, the full URL should be given and the date when the reference was last accessed. Any
further information, if known (DOI, author names, dates, reference to a source publication, etc.),
should also be given. Web references can be listed separately (e.g., after the reference list) under a
different heading if desired, or can be included in the reference list.
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References in a special issue
Please ensure that the words 'this issue' are added to any references in the list (and any citations in
the text) to other articles in the same Special Issue.
Reference style
Text: Indicate references by number(s) in square brackets in line with the text. The actual authors
can be referred to, but the reference number(s) must always be given.
List: Number the references (numbers in square brackets) in the list in the order in which they appear
in the text.
Examples:
Reference to a journal publication:
[1] Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. J Sci Commun
2010;163:51–9.
Reference to a book:
[2] Strunk Jr W, White EB. The elements of style. 4th ed. New York: Longman; 2000.
Reference to a chapter in an edited book:
[3] Mettam GR, Adams LB. How to prepare an electronic version of your article. In: Jones BS, Smith
RZ, editors. Introduction to the electronic age, New York: E-Publishing Inc; 2009, p. 281–304.
Reference to a website:
[4] Cancer Research UK. Cancer statistics reports for the UK, http://www.cancerresearchuk.org/
aboutcancer/statistics/cancerstatsreport/; 2003 [accessed 13.03.03].
Note shortened form for last page number. e.g., 51–9, and that for more than 6 authors the first 6
should be listed followed by 'et al.' For further details you are referred to 'Uniform Requirements for
Manuscripts submitted to Biomedical Journals' (J Am Med Assoc 1997;277:927–34) (see also Samples
of Formatted References).
Journal Abbreviations Source
Journal names should be abbreviated according to the List of Title Word Abbreviations:
http://www.issn.org/services/online-services/access-to-the-ltwa/. The correct abbreviation for AfJEM
is: Afr J Emerg Med
Video
Elsevier accepts video material and animation sequences to support and enhance your scientific
research. Authors who have video or animation files that they wish to submit with their article are
strongly encouraged to include links to these within the body of the article. This can be done in the
same way as a figure or table by referring to the video or animation content and noting in the body
text where it should be placed. All submitted files should be properly labeled so that they directly
relate to the video file's content. In order to ensure that your video or animation material is directly
usable, please provide the files in one of our recommended file formats with a preferred maximum size
of 150 MB. Video and animation files supplied will be published online in the electronic version of your
article in Elsevier Web products, including ScienceDirect. Please supply 'stills' with your files: you can
choose any frame from the video or animation or make a separate image. These will be used instead
of standard icons and will personalize the link to your video data. For more detailed instructions please
visit our video instruction pages. Note: since video and animation cannot be embedded in the print
version of the journal, please provide text for both the electronic and the print version for the portions
of the article that refer to this content.
Supplementary material
Supplementary material can support and enhance your scientific research. Supplementary files
offer the author additional possibilities to publish supporting applications, high-resolution images,
background datasets, sound clips and more. Please note that such items are published online exactly
as they are submitted; there is no typesetting involved (supplementary data supplied as an Excel
file or as a PowerPoint slide will appear as such online). Please submit the material together with the
article and supply a concise and descriptive caption for each file. If you wish to make any changes to
supplementary data during any stage of the process, then please make sure to provide an updated
file, and do not annotate any corrections on a previous version. Please also make sure to switch off the
'Track Changes' option in any Microsoft Office files as these will appear in the published supplementary
file(s). For more detailed instructions please visit our artwork instruction pages.
Additional information
Manuscripts should not exceed 30 typewritten pages for original articles and 6 typewritten pages for
short communications (incl. tables and fi gure legends). The editors reserve to themselves the right
of condensing any paper submitted.
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AFTER ACCEPTANCE
French title and abstract translation
Following acceptance of your paper and prior to proofs being returned to you for a final check, the
technical team will translate your manuscript title and abstract to French. This will be included in
the final proof.
Manuscript translation
Following acceptance authors are now encouraged to submit a self-translated version of their final
approved manuscript (title, abstract and text) into any Africa-relevant language (i.e. French, Arabic,
Swahili, Portuguese, etc.). The self-translated manuscript will be published as a supplementary file
along with the formal English version. The self-translated version will not be checked by the editing
team and the following notice will appear near the link to the self-translated version: A [language]
translation of this paper has been provided by the authors. The translation has not been check by
the editorial team.
The purpose of a self-translation is to improve the visibility and accessibility of the manuscript's
content. This should be kept in mind when the author(s) take the decision to provide a translation.
The translation should be provided in a Word document and sent directly to the editor in chief within
two weeks of acceptance. A cover page should precede the translation stating the Title of the paper in
English, the names of the Authors the Manuscript number and the language the paper was translated
in. The translation should include a title, abstract and the main manuscript (text, figures and tables)
each on a separate page. It should include citations but not the references as this is already available
in the main manuscript.
Proofs
One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do
not have an e-mail address then paper proofs will be sent by post) or, a link will be provided in the
e-mail so that authors can download the files themselves. Elsevier now provides authors with PDF
proofs which can be annotated; for this you will need to download the free Adobe Reader, version 9
(or higher). Instructions on how to annotate PDF files will accompany the proofs (also given online).
The exact system requirements are given at the Adobe site.
If you do not wish to use the PDF annotations function, you may list the corrections (including replies
to the Query Form) and return them to Elsevier in an e-mail. Please list your corrections quoting line
number. If, for any reason, this is not possible, then mark the corrections and any other comments
(including replies to the Query Form) on a printout of your proof and scan the pages and return via e-
mail. Please use this proof only for checking the typesetting, editing, completeness and correctness
of the text, tables and figures. Significant changes to the article as accepted for publication will only
be considered at this stage with permission from the Editor. We will do everything possible to get your
article published quickly and accurately. It is important to ensure that all corrections are sent back
to us in one communication: please check carefully before replying, as inclusion of any subsequent
corrections cannot be guaranteed. Proofreading is solely your responsibility.
Offprints
The corresponding author will, at no cost, receive a customized Share Link providing 50 days free
access to the final published version of the article on ScienceDirect. The Share Link can be used
for sharing the article via any communication channel, including email and social media. For an
extra charge, paper offprints can be ordered via the offprint order form which is sent once the
article is accepted for publication. Both corresponding and co-authors may order offprints at any
time via Elsevier's Webshop. Corresponding authors who have published their article open access do
not receive a Share Link as their final published version of the article is available open access on
ScienceDirect and can be shared through the article DOI link.
AUTHOR INQUIRIES
Visit the Elsevier Support Center to find the answers you need. Here you will find everything from
Frequently Asked Questions to ways to get in touch.
You can also check the status of your submitted article or find out when your accepted article will
be published.
© Copyright 2014 Elsevier | http://www.elsevier.com
 




Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or the abstract 
(b) Provide in the abstract an informative and balanced summary of what was done 
and what was found 
Introduction 
Background/rationale 2 Explain the scientific background and rationale for the investigation being reported 
Objectives 3 State specific objectives, including any prespecified hypotheses 
Methods 
Study design 4 Present key elements of study design early in the paper 
Setting 5 Describe the setting, locations, and relevant dates, including periods of recruitment, 
exposure, follow-up, and data collection 
Participants 6 (a) Cohort study—Give the eligibility criteria, and the sources and methods of 
selection of participants. Describe methods of follow-up 
Case-control study—Give the eligibility criteria, and the sources and methods of 
case ascertainment and control selection. Give the rationale for the choice of cases 
and controls 
Cross-sectional study—Give the eligibility criteria, and the sources and methods of 
selection of participants 
(b) Cohort study—For matched studies, give matching criteria and number of 
exposed and unexposed 
Case-control study—For matched studies, give matching criteria and the number of 
controls per case 
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and effect 
modifiers. Give diagnostic criteria, if applicable 
Data sources/ 
measurement 
8*  For each variable of interest, give sources of data and details of methods of 
assessment (measurement). Describe comparability of assessment methods if there 
is more than one group 
Bias 9 Describe any efforts to address potential sources of bias 
Study size 10 Explain how the study size was arrived at 
Quantitative variables 11 Explain how quantitative variables were handled in the analyses. If applicable, 
describe which groupings were chosen and why 
Statistical methods 12 (a) Describe all statistical methods, including those used to control for confounding 
(b) Describe any methods used to examine subgroups and interactions 
(c) Explain how missing data were addressed 
(d) Cohort study—If applicable, explain how loss to follow-up was addressed 
Case-control study—If applicable, explain how matching of cases and controls was 
addressed 
Cross-sectional study—If applicable, describe analytical methods taking account of 
sampling strategy 
(e) Describe any sensitivity analyses 




Participants 13* (a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, 
examined for eligibility, confirmed eligible, included in the study, completing follow-up, and 
analysed 
(b) Give reasons for non-participation at each stage 
(c) Consider use of a flow diagram 
Descriptive 
data 
14* (a) Give characteristics of study participants (eg demographic, clinical, social) and information 
on exposures and potential confounders 
(b) Indicate number of participants with missing data for each variable of interest 
(c) Cohort study—Summarise follow-up time (eg, average and total amount) 
Outcome data 15* Cohort study—Report numbers of outcome events or summary measures over time 
Case-control study—Report numbers in each exposure category, or summary measures of 
exposure 
Cross-sectional study—Report numbers of outcome events or summary measures 
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their 
precision (eg, 95% confidence interval). Make clear which confounders were adjusted for and 
why they were included 
(b) Report category boundaries when continuous variables were categorized 
(c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful 
time period 
Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and sensitivity 
analyses 
Discussion 
Key results 18 Summarise key results with reference to study objectives 
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or imprecision. 
Discuss both direction and magnitude of any potential bias 
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, multiplicity 
of analyses, results from similar studies, and other relevant evidence 
Generalisability 21 Discuss the generalisability (external validity) of the study results 
Other information 
Funding 22 Give the source of funding and the role of the funders for the present study and, if applicable, 
for the original study on which the present article is based 
 
*Give information separately for cases and controls in case-control studies and, if applicable, for exposed and 
unexposed groups in cohort and cross-sectional studies. 
 
Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and 
published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely 
available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at 
http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is 
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Appendix	3:	
	
	
	
Taken	directly	from:		 Ouellette	DW,	Patocka	C.	Pulmonary	embolism.	Emergency	medicine	clinics	of	North	
America.	2012;30(2):329-75.	
	
	
	
	
	
